Her clinical expertise encompasses the management of hematologic cancers and the application of stem cell transplantation in both malignant and non-malignant disorders, such as sickle cell anemia. Dr. Filicko-O’Hara has contributed to research on immune reconstitution following stem cell transplantation and has been involved in studies evaluating the efficacy of various treatment regimens for hematologic malignancies. She has also co-authored publications on topics like the use of bendamustine in combination with other agents for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma and the treatment of adenovirus disease in stem cell transplant recipients.
Joanne E. Filicko-O'Hara, MD
Associate Program Director, Combined Fellowship in Hematology/Medical Oncology
Professor
Contact Information
Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Associate Program Director, Combined Fellowship in Hematology/Medical Oncology
Professor
RESEARCH & CLINICAL INTEREST
Education
Medical School
Hahnemann University School of Medicine - 1992
Residency
Thomas Jefferson University Hospital - 1995
Fellowship
Thomas Jefferson University Hospital - 1998
Most Recent Peer-Reviewed Publications
- Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
- Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation
- Chronic lymphocytic leukemia/small lymphocytic lymphoma with pancytopenia and chylothorax
- Testicular lymphoma
- Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease
Board Certifications
Hematology
Medical Oncology